QQQ   437.27 (+0.16%)
AAPL   180.76 (-0.22%)
MSFT   405.41 (-0.52%)
META   483.31 (+0.33%)
GOOGL   137.75 (+0.13%)
AMZN   174.22 (-0.29%)
TSLA   202.40 (+1.50%)
NVDA   792.04 (+0.14%)
NIO   5.77 (+2.12%)
AMD   178.16 (+1.22%)
BABA   77.61 (+1.44%)
T   16.61 (+0.06%)
F   12.07 (+1.00%)
MU   91.44 (+2.21%)
CGC   3.56 (+2.59%)
GE   153.74 (-0.67%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.98 (-0.74%)
PYPL   59.99 (+1.11%)
XOM   104.23 (-0.02%)
QQQ   437.27 (+0.16%)
AAPL   180.76 (-0.22%)
MSFT   405.41 (-0.52%)
META   483.31 (+0.33%)
GOOGL   137.75 (+0.13%)
AMZN   174.22 (-0.29%)
TSLA   202.40 (+1.50%)
NVDA   792.04 (+0.14%)
NIO   5.77 (+2.12%)
AMD   178.16 (+1.22%)
BABA   77.61 (+1.44%)
T   16.61 (+0.06%)
F   12.07 (+1.00%)
MU   91.44 (+2.21%)
CGC   3.56 (+2.59%)
GE   153.74 (-0.67%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.98 (-0.74%)
PYPL   59.99 (+1.11%)
XOM   104.23 (-0.02%)
QQQ   437.27 (+0.16%)
AAPL   180.76 (-0.22%)
MSFT   405.41 (-0.52%)
META   483.31 (+0.33%)
GOOGL   137.75 (+0.13%)
AMZN   174.22 (-0.29%)
TSLA   202.40 (+1.50%)
NVDA   792.04 (+0.14%)
NIO   5.77 (+2.12%)
AMD   178.16 (+1.22%)
BABA   77.61 (+1.44%)
T   16.61 (+0.06%)
F   12.07 (+1.00%)
MU   91.44 (+2.21%)
CGC   3.56 (+2.59%)
GE   153.74 (-0.67%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.98 (-0.74%)
PYPL   59.99 (+1.11%)
XOM   104.23 (-0.02%)
QQQ   437.27 (+0.16%)
AAPL   180.76 (-0.22%)
MSFT   405.41 (-0.52%)
META   483.31 (+0.33%)
GOOGL   137.75 (+0.13%)
AMZN   174.22 (-0.29%)
TSLA   202.40 (+1.50%)
NVDA   792.04 (+0.14%)
NIO   5.77 (+2.12%)
AMD   178.16 (+1.22%)
BABA   77.61 (+1.44%)
T   16.61 (+0.06%)
F   12.07 (+1.00%)
MU   91.44 (+2.21%)
CGC   3.56 (+2.59%)
GE   153.74 (-0.67%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.98 (-0.74%)
PYPL   59.99 (+1.11%)
XOM   104.23 (-0.02%)
NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

$13.20
+0.11 (+0.84%)
(As of 12:21 PM ET)
Today's Range
$13.15
$13.22
50-Day Range
$12.47
$13.86
52-Week Range
$9.76
$14.20
Volume
19,674 shs
Average Volume
79,718 shs
Market Capitalization
$828.96 million
P/E Ratio
41.25
Dividend Yield
N/A
Price Target
$20.33

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
54.0% Upside
$20.33 Price Target
Short Interest
Healthy
1.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of Bioceres Crop Solutions in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
125.00%
From $0.48 to $1.08 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.36 out of 5 stars

Consumer Staples Sector

65th out of 135 stocks

Agricultural Chemicals Industry

6th out of 10 stocks


BIOX stock logo

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

BIOX Stock News Headlines

Bioceres Crop Solutions Corp
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp (BIOX)
Earnings Preview For Bioceres Crop Solutions
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Bioceres Crop Solutions Corp. (BIOX)
Beware Of Impending Dilution At Bioceres
Earnings Outlook For Bioceres Crop Solutions
Bioceres Crop Solutions Corp BIOX
Bioceres Crop Solutions Corp. (KYG1117K1141.SG)
Bioceres Crop Solutions' HB4 Technology: A Game Changer
See More Headlines
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
2/26/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
447
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.33
High Stock Price Target
$25.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+55.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$18.78 million
Pretax Margin
5.55%

Debt

Sales & Book Value

Annual Sales
$419.80 million
Cash Flow
$0.57 per share
Book Value
$5.26 per share

Miscellaneous

Free Float
N/A
Market Cap
$822.05 million
Optionable
Optionable
Beta
0.54
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Jose A. Roque
    General Counsel
  • Alex Garcia
    Managing Director of Seeds
  • Dr. Federico Trucco Ph.D. (Age 47)
    Chairman & CEO
    Comp: $131.16k
  • Mr. Enrique López Lecube (Age 42)
    CFO & Executive Director
    Comp: $129.89k
  • Mr. Jorge Wagner (Age 55)
    Chief Operating Officer
    Comp: $165.6k
  • Ms. Paula Savanti
    Head of Investor Relations
  • Mr. Ricardo Luis Yapur (Age 65)
    Managing Director of Latam Unit & Chief Commercial Officer
    Comp: $260k
  • Mr. Matti Tiainen (Age 34)
    Managing Director of North America & Europe














BIOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bioceres Crop Solutions stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BIOX shares.
View BIOX analyst ratings
or view top-rated stocks.

What is Bioceres Crop Solutions' stock price target for 2024?

3 brokers have issued twelve-month target prices for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $15.00 to $25.00. On average, they anticipate the company's share price to reach $20.33 in the next year. This suggests a possible upside of 54.0% from the stock's current price.
View analysts price targets for BIOX
or view top-rated stocks among Wall Street analysts.

How have BIOX shares performed in 2024?

Bioceres Crop Solutions' stock was trading at $13.73 at the beginning of the year. Since then, BIOX stock has decreased by 3.9% and is now trading at $13.20.
View the best growth stocks for 2024 here
.

When is Bioceres Crop Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our BIOX earnings forecast
.

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) released its quarterly earnings results on Thursday, February, 8th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.07 by $0.02. The firm earned $140.30 million during the quarter, compared to analysts' expectations of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a trailing twelve-month return on equity of 5.96%. During the same quarter in the prior year, the business posted ($0.14) EPS.

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS), Celldex Therapeutics (CLDX), Chimerix (CMRX), CTI BioPharma (CTIC).

When did Bioceres Crop Solutions IPO?

(BIOX) raised $130 million in an IPO on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' stock is owned by many different retail and institutional investors. Top institutional investors include Fourth Sail Capital LP (1.10%), Mirae Asset Global Investments Co. Ltd. (0.22%), Federated Hermes Inc. (0.07%), Primecap Management Co. CA (0.06%), Stifel Financial Corp (0.05%) and UBS Group AG (0.05%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIOX) was last updated on 2/27/2024 by MarketBeat.com Staff